Conclusion: In diabetic patients with post-amputation wounds, negative pressure wound therapy heals a greater proportion of patients with less resource utilization than standard moist wound therapy. Summary: There were 162 patients with diabetes and post-amputation wounds entered into a 16 week randomized clinical trial. Seventy-seven patients were randomized to negative pressure wound therapy NPWT) and received dressing changes every 48 hours. Eighty-five patients received standard moist wound (MWT) therapy according to consensus guidelines (Wound Ostemy Continence Nursing Society. Guideline for Management of Wounds in Patients with Lower Extremity Neuropathic Disease. WOCN Glennville, IL; 2004: 57). Direct costs, procedures, and resource utilization were analyzed in a post-op retrospective analysis. In the NPWT v. MWT groups, there were no differences in inpatient hospital stay either in terms of number of admissions or length of stay. There were more debridement procedures required in the MWT group (120 v. 43, p<0.001). The average number of dressing changes per patient in the MWT group was 118 (range 12-226) v. 41 (6-140) for NPWT, p=0.0001. The average direct cost per patient for 8 weeks of treatment or longer was $27,220 for the NPWT group and $36,096 for the MWT group. The average total cost to achieve healing was $25,954 in patients treated with NPWT (n=43) compared with $38,806 for the MWT group (n=33). Comment: It is very expensive to heal wounds. The study suggests negative pressure therapy for open diabetic wounds is cheaper and more effective than standard moist wound therapy. Costs in the MWT group were driven primarily by dressing changes and antibiotic costs. It is likely that the costs presented are conservative. Costs related to transportation, inpatient dressing changes, prosthesis and rehabilitation were not included in the analysis. Note the authors have affiliations with KCI, the manufacturer of the negative pressure device used in this study.
Read full abstract